Applications of the Amplatzer Vascular Plug to various vascular lesions

Abstract

The Amplatzer® Vascular Plug (AVP) can be used to embolize medium-to-large high-flow vessels in various locations. Between 2009 and 2012, 41 AVPs (device size, 6-22 mm in diameter) were used to achieve occlusion in 31 patients (24 males, seven females) aged 9-92 years (mean age, 54.5 years). The locations and indications for embolotherapy were as follows: internal iliac artery embolization before stent-graft repair for aorto-iliac (n=6) and common iliac artery (n=3) aneurysms, subclavian artery embolization before stent-graft repair for thoracic aorta (n=3) and arcus aorta (n=1) aneurysms, brachiocephalic trunk embolization before stent-graft repair for a thoracic aorta aneurysm (n=1), embolization of aneurysms and pseudoaneurysms (n=5), embolization for carotid blow-out syndrome (n=3), closure of arteriovenous fistula (n=8), and closure of a portosystemic fistula (n=1). Of the 41 AVPs, 30 were AVP 2 and 11 were AVP 4. The mean follow-up duration was 4.7 months (range, 1-24 months). During follow-up, there was one migration, one insufficient embolization, and one recanalization. The remaining vascular lesions were successfully excluded from the circulation. The AVP, which can be used in a wide spectrum of pathologies, is easy to use and causes few complications. This essay presents our experience with the AVP.

Diagn Interv Radiol 2014; 20:155159

Turkish Society of Radiology 2014

INTERVENTIONAL RADIOLOGY

PICTORIAL ESSAY

Applications of the Amplatzer Vascular Plug to various vascular lesions

Serkan Gneyli, Celal nar, Halil Bozkaya, Mustafa Parldar, smail Oran

The Amplatzer Vascular Plug (AVP, AGA Medical Corp., Golden Valley, Minnesota, USA) is a good alternative to other embolic materials (1). The AVP has many advantages over embolic materials

such as coils or glue. It is retractable, and it can be repositioned. Use of the AVP has cost advantages over other embolic materials. It can be used safely in trauma patients or in patients before endovascular aortic repair (EVAR). It ensures permanent occlusion, and its migration risk is less than for coils. The results of embolization with the AVP have been excellent (2), and no contraindications for its use have been reported (3). All four types of AVP have two components: a vascular plug and a delivery wire. The plugs have radiopaque platinum marker bands at both ends (4). The AVP 2 contains a more densely woven nitinol mesh and minimizes migration and recanalization (5). The AVP 4 is used mostly in small, tortuous vessels (6). The AVP is made of self-expanding material, and it returns to its original shape after release from the catheter. It has a long delivery cable, is preloaded in a loader, and is delivered through guiding catheters ranging from 5 to 8 F in size. The AVP is released by rotating the delivery cable counterclockwise.

Thirty-one patients (24 males, seven females) aged 992 years (mean age, 54.5 years), who underwent percutaneous occlusion with the AVP at our hospital between 2009 and 2012, were evaluated retrospectively. Patients with any pathology involving AVP use for embolization were included in this study. Patients in whom only other embolic materials were used were excluded. The study was approved by the Institutional Review Board and consent was obtained from the patients before the procedures. Most patients underwent general anesthesia. A transfemoral arterial or venous approach was used in most patients. In the patient with a portosystemic fistula, a transjugular approach was used. The procedures were performed under heparinization only in patients with a pulmonary arteriovenous fistula (AVF) or thoracic aorta aneurysm.

In 24 of the 31 patients, we used only the AVP as the embolic material. In the remaining seven patients, we used the AVP with coils. In six of the 31 patients, more than one AVP was used. In total, 41 AVPs (30 AVP 2, 11 AVP 4), 622 mm in diameter, were used. The diameter of the AVP was selected to be 30%50% larger than that of the targeted location in each patient. Computed tomography (CT) angiography was used most commonly for follow-up imaging (mean follow-up duration, 4.7 months; range, 124 months). This pictorial essay presents our experience using the AVP in various locations as material to embolize medium-to-large vessels with high flow.

Internal iliac artery embolization to prevent endoleakage

Left internal iliac artery embolization was performed before EVAR in five males and one female with aorto-bi-iliac aneurysms: a 71-year-old male with a 16 mm AVP 2, a 68-year-old male with a 12 mm AVP 2 and coils, a 66-year-old male with a 12 mm AVP 2, a 71-year-old male with

ABSTRACTThe Amplatzer Vascular Plug (AVP) can be used to embolize medium-to-large high-ow vessels in various locations. Between 2009 and 2012, 41 AVPs (device size, 622 mm in diameter) were used to achieve occlusion in 31 patients (24 males, seven females) aged 992 years (mean age, 54.5 years). The locations and indications for embolotherapy were as follows: internal iliac artery embolization before stent-graft repair for aorto-iliac (n=6) and common iliac artery (n=3) aneurysms, subclavian artery embolization before stent-graft repair for thoracic aorta (n=3) and arcus aorta (n=1) aneurysms, brachiocephalic trunk embolization before stent-graft repair for a thoracic aorta aneurysm (n=1), embolization of aneurysms and pseudoaneurysms (n=5), embolization for carotid blow-out syndrome (n=3), closure of arteriovenous stula (n=8), and closure of a portosystemic stula (n=1). Of the 41 AVPs, 30 were AVP 2 and 11 were AVP 4. The mean follow-up duration was 4.7 months (range, 124 months). During follow-up, there was one migration, one insufcient embolization, and one recanalization. The remaining vascular lesions were successfully excluded from the circulation. The AVP, which can be used in a wide spectrum of pathologies, is easy to use and causes few complications. This essay presents our experience with the AVP.

From the Department of Radiology (S.G. serkanguneyli@yahoo. com), Ege University School of Medicine, zmir, Turkey.

Received 21 March 2013; revision requested 14 April 2013; revision received 27 June 2013; accepted 6 July 2013.

Published online 13 September 2013.

DOI 10.5152/dir.2013.13139

155

a 10 mm AVP 2 and coils, a 74-year-old male with an 18-mm AVP 2, and a 43-year-old female with a 10 mm AVP 2. Unilateral internal iliac artery embolization with a 12 mm AVP 2 was performed in a 56-year-old female and a 73-year-old male with unilateral common iliac artery aneurysms. Bilateral internal iliac artery embolization with two 12 mm AVP 2 was performed in a 59-year-old male with bilateral common iliac artery aneurysms.

Subclavian artery and brachiocephalic trunk embolization to prevent endoleakage

The left subclavian artery was embolized before thoracic EVAR in three patients with a thoracic aorta aneurysm (a 62-year-old male with a 14 mm AVP 2, a 78-year-old female with a 12 mm AVP 2, and a 67-year-old male with a 10 mm AVP 2) and in a 73-year-old male with an arcus aorta aneurysm (with a 14 mm AVP 2). In a 63-year-old male with a thoracic aorta aneurysm, the brachiocephalic trunk was embolized with a 12 mm AVP 2, and because of insufficient embolization, re-embolized with a 16 mm AVP 2 after one month.

Aneurysm or pseudoaneurysm embolization

In a 56-year-old male with an aberrant right subclavian artery aneurysm and type 3 aortic dissection, the aneurysm was occluded with an 18 mm AVP 2. The right cavernous internal carotid artery aneurysm of an 18-year-old female was treated with a 7 mm AVP 4, an 8 mm AVP 4, and coils. In a 63-year-old male, the proximal and distal parts of the common hepatic artery aneurysm were occluded with a 10 and 2 mm AVP 2, respectively (Fig. 1). In a 46-year-old male with a left deep femoral artery pseudoaneurysm and traumatic AVF, the AVF was embolized with coils, and the pseudoaneurysm was embolized with an 8 mm AVP 4. In a 32-year-old male with a traumatic thyrocervical trunk pseudoaneurysm, embolization with a 6 mm AVP 4 was performed.

Embolization for carotid blow-out syndrome

Two patients with inoperable larynx cancer underwent common carotid artery embolization for carotid blow-out syndrome: a 68-year-old male with a 12 mm AVP 2 and coils and a 58-year-old male with a 14 mm AVP 2 and coils. A 47-year-old male with hypopharynx

a b

Figure 1. a, b. Coronal CT angiography reconstruction images of a 63-year-old male show a partially thrombosed common hepatic artery aneurysm (a, arrows) and two AVPs placed in the proximal and distal parts of the aneurysm (b, arrows) one month after the occlusion.

a

b

c

d

Figure 2. ad. Axial CT angiography image (a) of a 47-year-old male shows a pseudoaneurysm (arrow) in the left parapharyngeal space. A sagittal CT angiography reconstruction image (b) shows a left internal maxillary artery pseudoaneurysm (arrow). Selective left external carotid angiography (c) shows active contrast extravasation from the pseudoaneurysm (arrow). Selective left external carotid angiography after the deployment of an 8 mm AVP 2 (d) shows total embolization of the left internal maxillary artery (arrow).

156 MarchApril 2014 Diagnostic and Interventional Radiology Gneyli et al.

a

b

c

d

Figure 3. ad. Coronal CT angiography reconstruction image (a) of a 62-year-old male shows a caroticojugular stula (arrow) between the internal carotid artery and internal jugular vein. Carotid angiography (b) shows the caroticojugular stula (arrow). One month following the embolization, a sagittal CT angiography reconstruction image (c) shows the occluded left external carotid artery with an 8 mm AVP 4 (black arrow) and the occluded stula with a stent-graft (white arrow). One month following the embolization, a coronal CT angiography reconstruction image (d) shows the occluded left external carotid artery with the AVP 4 (black arrow) and the occluded stula with the stent-graft (white arrow).

cancer and a left internal maxillary artery pseudoaneurysm underwent internal maxillary artery embolization for carotid blow-out syndrome with an 8 mm AVP 2 (Fig. 2).

Arteriovenous and portosystemic stulas embolization

In a 62-year-old male with a left traumatic high-flow caroticojugular fistula, the left external carotid artery

was embolized with an 8 mm AVP 4 to prevent retrograde filling from the external carotid artery, and subsequently the fistula between the internal carotid artery and internal jugular vein was occluded with a stent-graft (Fig. 3). In a 57-year-old male with a right traumatic high-flow caroticojugular fistula between the common carotid artery and internal jugular vein, the right internal carotid artery and external carotid artery were embolized with three AVPs to prevent retrograde filling, and then three AVPs were placed in the right facial artery and common carotid artery to occlude the fistula (with a 12 mm and a 20 mm AVP 2 and two 6, a 7, and an 8 mm AVP 4) (Fig. 4). In a 17-year-old female with a pulmonary AVF secondary to Osler-Weber-Rendu syndrome, the right-middle lobe segment pulmonary artery was embolized with a 16 mm AVP 2 (Fig. 5). The renal AVF of an 11-year-old male, who underwent a renal biopsy one year earlier following renal transplantation, was occluded with an 8 mm AVP 4 (Fig. 6). A 14 mm and a 22 mm AVP 2 were used to occlude a dysfunctional brachiocephalic hemodialysis fistula in a 92-year-old female. A 14 mm AVP 2, a 6 mm AVP 4, and coils were used to occlude a left traumatic internal iliac AVF in a 32-year-old male. A 22 mm (the largest diameter AVP) AVP 2 was placed between the left portal vein and left hepatic vein for the congenital high-flow portosystemic fistula of a nine-year-old male.

Two patients with fistulas had complications. In a 70-year-old male with a ruptured abdominal aortic aneurysm and aortocaval fistula, a 20 mm AVP 2 was used to occlude the fistula. Twelve hours later, the AVP 2 migrated to the right-lower lobe segment pulmonary artery without clinical consequences. Three months following the migration, the fistula was re-embolized with coils, and the migrated AVP 2 was left in the pulmonary artery. In a 28-year-old female with a pulmonary high-flow AVF secondary to Osler-Weber-Rendu syndrome, the left-lower lobe segment pulmonary artery was occluded with a 14 mm AVP 2; because of recanalization in the pulmonary AVF, embolization with a 12 mm AVP 2 and coils was performed 16 months after the first embolization.

Amplatzer Vascular Plug in various vascular lesions 157

a

b

c

Figure 4. ae. Coronal CT angiography reconstruction image (a) of a 57-year-old male shows a caroticojugular stula (arrow) between the common carotid artery and internal jugular vein. A coronal CT angiography reconstruction image (b) shows the dilated internal jugular vein (arrow) secondary to the caroticojugular stula. Carotid angiography (c) showsthe caroticojugular stula (arrow). Carotid angiography after deployment of the AVPs (d) shows multiple AVPs. Carotid angiography after deployment of the AVPs (e) shows total embolization of the common carotid artery (arrow).

d

e

Conclusion

In the embolization of arteries, which are high-flow vessels, migration of the AVP is very rare (7). Internal iliac artery embolization is one of the most commonly reported applications of the AVP in arterial embolization, because if a common iliac artery aneurysm extends

to the common iliac artery bifurcation in a patient with or without abdominal aortic aneurysm, simply extending the endograft into the external iliac artery beyond the internal iliac artery orifice could result in type 2 endoleakage (8). The AVP has been used in neurointervention (911), venous pathologies (12, 13),

and abnormal vascular (14) and nonvascular connections.

Use of the AVP has some limitations. First, a 58 F guiding catheter is required. In addition, the AVP is unsuitable for vessels that are too small or too large. Nineteen patients had no complications, and three patients had complications. The remaining nine pa-

158 MarchApril 2014 Diagnostic and Interventional Radiology Gneyli et al.

Conict of interest disclosure

The authors declared no conflicts of interest.

References

1. Ong CK, Lam DV, Ong MT, Power MA, Parkinson RJ, Wenderoth JD. Neuroapplication of Amplatzer Vascular Plug for therapeutic sacrifice of major craniocerebral arteries: an initial clinical experience. Ann Acad Med Singap 2009; 38:763768.

2. Hill SL, Hijazi ZM, Hellenbrand WE, Cheatham JP. Evaluation of the Amplatzer Vascular Plug for embolization of peripheral vascular malformations associated with http://dx.doi.org/10.1002/ccd.20555

Web End =congenital heart disease. Catheter Cardio http://dx.doi.org/10.1002/ccd.20555

Web End =vasc Interv 2006; 67:113119. [CrossRef]

3. Mangini M, Lagana D, Fontana F, et al. Use of Amplatzer Vascular Plug (AVP) in emergency embolisation: preliminary exhttp://dx.doi.org/10.1007/s10140-007-0696-8

Web End =perience and review of literature. Emerg http://dx.doi.org/10.1007/s10140-007-0696-8

Web End =Radiol 2008; 15:153160. [CrossRef]

4. Schwartz M, Glatz AC, Rome JJ, Gillespie MJ. The Amplatzer vascular plug and Amplatzer Vascular Plug II for vascular occlusion procedures in 50 patients with congenital cardiohttp://dx.doi.org/10.1002/ccd.22370

Web End =vascular disease. Catheter Cardiovasc Interv http://dx.doi.org/10.1002/ccd.22370

Web End =2010; 76:411417. [CrossRef]

5. Tabori NE, Love BA. Transcatheter occlusion of pulmonary arteriovenous malformations using the Amplatzer Vascular http://dx.doi.org/10.1002/ccd.21474

Web End =Plug II. Catheter Cardiovasc Interv 2008; http://dx.doi.org/10.1002/ccd.21474

Web End =71:940943. [CrossRef]

6. Yildiz AE, Peynircioglu B, Cil BE. Applications of the Amplatzer Vascular Plug 4. Diagn Interv Radiol 2012; 18:225230.

7. Cho YK, Chang NK, Ma JS. Successful transcatheter closure of a large patent ductus venosus with the Amplatzer http://dx.doi.org/10.1007/s00246-009-9397-2

Web End =Vascular Plug II. Pediatr Cardiol 2009; http://dx.doi.org/10.1007/s00246-009-9397-2

Web End =30:540542. [CrossRef]

8. Vandy F, Criado E, Upchurch GR Jr, Williams DM, Rectenwald J, Eliason J. Transluminal hypogastric artery occlusion with an Amplatzer Vascular Plug during endovascular aortic aneurysm http://dx.doi.org/10.1016/j.jvs.2008.06.002

Web End =repair. J Vasc Surg 2008; http://dx.doi.org/10.1016/j.jvs.2008.06.002

Web End =48:11211124. [CrossRef]

9. Mordasini P, Schroth G, Brekenfeld C, Fung C, Hoppe H, Gralla J. Endovascular treatment of a traumatic direct carotid-cavernous fistula using the Amplatzer http://dx.doi.org/10.1583/10-3022.1

Web End =Vascular Plug II. J Endovasc Ther 2010; http://dx.doi.org/10.1583/10-3022.1

Web End =17:564568. [CrossRef]

10. Hoit DA, Schirmer CM, Malek AM. Use of the Amplatzer Vascular Plug as an anchoring scaffold for coil-mediated parent vessel http://dx.doi.org/10.1227/01.NEU.0000219856.66842.EF

Web End =occlusion: technical case report. Neurosur http://dx.doi.org/10.1227/01.NEU.0000219856.66842.EF

Web End =gery 2006; 59:171172. [CrossRef]

11. Shankar JJ, Maloney WJ, Vandorpe R. Amplatzer Vascular Plug for occlusion of parent artery in carotid blowout with active extravasation. Interv Neuroradiol 2011; 17:224227.

12. Cil B, Peynircioglu B, Canyigit M, Geyik S, Ciftci T. Peripheral vascular applications of the Amplatzer Vascular Plug. Diagn Interv Radiol 2008; 14:3539.

13. Yoo H, Ko GY, Gwon DI, et al. Preoperative portal vein embolization using an http://dx.doi.org/10.1007/s00330-008-1240-2

Web End =Amplatzer Vascular Plug. Eur Radiol 2009; http://dx.doi.org/10.1007/s00330-008-1240-2

Web End =19:10541061. [CrossRef]

14. Gillespie MJ, Golden A, Sivarajan VB, Rome JJ. Transcatheter closure of patent ductus venosus with the Amplatzer vascuhttp://dx.doi.org/10.1007/s00246-005-1081-6

Web End =lar plug in twin brothers. Pediatr Cardiol http://dx.doi.org/10.1007/s00246-005-1081-6

Web End =2006; 27:142145. [CrossRef]

a

b

c

d

Figure 5. ad. Axial CT angiography (a) and pulmonary angiography (b) images of a 17-year-old female show a pulmonary arteriovenous stula (arrow) at the right middle lobe. Pulmonary angiography after deployment of a 16 mm AVP 2 (c) shows total occlusion of the feeding artery and the AVP 2 (arrow) in the right middle lobe segment pulmonary artery. Six months later, an axial CT angiography image (d) shows the AVP 2 (arrow) in the right middle lobe segmental pulmonary artery.

a b

Figure 6. a, b. Renal angiography image (a) of an 11-year-old male shows a renal arteriovenous stula (arrow) at the mid to lower third of the kidney. Renal angiography after deploying an 8 mm AVP 4 (b) shows total occlusion (arrow) of the stula.

tients were followed only clinically.

In conclusion, we ensured controlled, permanent occlusions in our cases with the use of functional and

effective AVP, which costs less than other embolic materials (8). With improvements in its design, the clinical indications for the AVP will increase.

Amplatzer Vascular Plug in various vascular lesions 159